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Age-related diseases may result from shared biological mechanisms in intrinsic
processes of aging. Genetic effects on age-related diseases are often modulated by
environmental factors due to their little contribution to fitness or are mediated through
certain endophenotypes. Identification of genetic variants with pleiotropic effects on
both common complex diseases and endophenotypes may reveal potential conflicting
evolutionary pressures and deliver new insights into shared genetic contribution to
healthspan and lifespan. Here, we performed pleiotropic meta-analyses of genetic
variants using five NIH-funded datasets by integrating univariate summary statistics for
age-related diseases and endophenotypes. We investigated three groups of traits: (1)
endophenotypes such as blood glucose, blood pressure, lipids, hematocrit, and body
mass index, (2) time-to-event outcomes such as the age-at-onset of diabetes mellitus
(DM), cancer, cardiovascular diseases (CVDs) and neurodegenerative diseases (NDs),
and (3) both combined. In addition to replicating previous findings, we identify seven
novel genome-wide significant loci (<5e-08), out of which five are low-frequency variants.
Specifically, from Group 2, we find rs7632505 on 3q21.1 in SEMA5B, rs460976 on
21q22.3 (1 kb from TMPRSS2) and rs12420422 on 11q24.1 predominantly associated
with a variety of CVDs, rs4905014 in ITPK1 associated with stroke and heart failure,
rs7081476 on 10p12.1 in ANKRD26 associated with multiple diseases including DM,
CVDs, and NDs. From Group 3, we find rs8082812 on 18p11.22 and rs1869717 on
4q31.3 associated with both endophenotypes and CVDs. Our follow-up analyses show
that rs7632505, rs4905014, and rs8082812 have age-dependent effects on coronary
heart disease or stroke. Functional annotation suggests that most of these SNPs are
within regulatory regions or DNase clusters and in linkage disequilibrium with expression
quantitative trait loci, implying their potential regulatory influence on the expression of
nearby genes. Our mediation analyses suggest that the effects of some SNPs are
mediated by specific endophenotypes. In conclusion, these findings indicate that loci
with pleiotropic effects on age-related disorders tend to be enriched in genes involved
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in underlying mechanisms potentially related to nervous, cardiovascular and immune
system functions, stress resistance, inflammation, ion channels and hematopoiesis,
supporting the hypothesis of shared pathological role of infection, and inflammation in
chronic age-related diseases.
Keywords: pleiotropic analysis, age-related traits, CVDs, genetic association study, mediation analysis,
age-dependent effects
INTRODUCTION
Common age-related diseases including cancer, cardiovascular
diseases (CVDs), diabetes mellitus (DM), and neurodegenerative
diseases (NDs) such as Alzheimer’s disease (AD) and dementia
are major contributors to morbidity and mortality at old
age. The underlying hypothesis in gerontology posits that
these devastating diseases share some common mechanisms
in intrinsic processes of aging that remain to be determined
(Kaeberlein et al., 2015). Identifying genetic variants associated
with multiple age-related diseases (i.e., pleiotropic effects) is a
fundamental step toward understanding the genetic contribution
to age-related processes. Numerous loci have been identified
to show association across distinct diseases such as immune-
related disorders, cancer and NDs, highlighting the common
underlying biological pathways in the etiology of these complex
diseases (Sivakumaran et al., 2011). For example, variants in
APOE significantly associated with longevity and lifespan also
confer risk of CVDs, AD and cancer (Ewbank, 2002; Christensen
et al., 2006; Brooks-Wilson, 2013; Kulminski et al., 2014, 2015a).
A putative loss of function variant in PTPN22 has been found
to reduce the risk of Crohn’s disease but to increase the risk
of rheumatoid arthritis and DM (Plenge et al., 2005; Todd
et al., 2007; Barrett et al., 2008). On the other hand, evidence
suggests that many age-related diseases are associated with a
variety of intermediate phenotypes (also called endophenotypes,
i.e., a hereditary characteristic that normally relates to some
condition but is not a direct symptom per se) such as body
mass index (BMI), lipids, etc. It has been noted from previous
genome-wide association studies (GWAS) that different diseases
and endophenotypes can be linked by shared genetic variants
(Li et al., 2014). These observations demonstrate the clinical
benefits from characterization of shared genetic causes that have
pleiotropic effects on different phenotypes related to aging. Thus,
there has been an increasing interest in jointly interrogating the
cross-phenotype association of genetic variants.
Pleiotropic analysis generally provide more information on
the common underlying biological mechanism and guidance of
further functional studies (Solovieff et al., 2013; Price et al.,
2015). In many cases, considering multiple phenotypes together
boosts statistical power by aggregating marginal effects on
individual phenotypes. Single nucleotide polymorphisms (SNPs)
with moderate causal effects on each phenotype may happen not
to reach significance when interrogating them separately. Multi-
trait analysis has been demonstrated to yield enhanced statistical
power for detecting the quantitative trait loci (QTL) that are
associated with multiple traits (Korol et al., 2001). Moreover,
once genetic pleiotropy is identified, it is of interest to further
discriminate between a biological and mediated pleiotropy
(Solovieff et al., 2013). The former refers to a direct independent
biological effect of a variant on more than one phenotype,
while the latter refers to a situation in which the effect on one
phenotype ismediated by another phenotype so that the variant is
indirectly associated with the second. Given the identified genetic
variant having pleiotropic effect on a pair of phenotypes, causal
inference under certain specific assumptions can provide insights
into potential causal pathways and contribute to characterizing
the underlying biological mechanisms. For example, given the
causal relationship between low-density lipoprotein (LDL) and
myocardial infarction (MI), conducting mediation analysis on
a variant associated with both can provide evidence of which
pathological pathway the variant is probably involved in. Finally,
it should be noted that although previous GWAS following the
traditional biomedical strategy have attempted to discover genes
conferring risks of age-related diseases, the SNPs associated with
them in general are not subject to direct evolutionary selection
as these diseases occur during the post-reproductive period so
that these SNPs hardly contribute to fitness (Nesse et al., 2012).
Therefore, any effect of such SNPs on the diseases is probably
mediated through their effects on certain endophenotypes or
is modulated by environmental factors (e.g., the grandmother
effect; Lahdenperä et al., 2004). Consequently, effects of relevant
variants are often found to be environment-specific and to
have different temporal patterns (De Benedictis and Franceschi,
2006; Kulminski, 2013; Yashin et al., 2015). In this case,
pleiotropic analysis combined with follow-up mediation analysis
and annotation with various expression and regulatory database
resources can serve as a substantive tool to elucidate the potential
mediator and causality behind the association between SNPs
and age-related diseases, which may explain inconsistent genetic
effects in different populations even in case of populations of the
same ancestry and perfectly harmonized phenotypes (Kulminski,
2013; Yashin et al., 2015).
Over the past decade, GWAS have seen unprecedented
success; however, most studies focused on individual phenotypes.
While approximately >10,000 genome-wide significant SNPs
have been identified to be associated with various phenotypes,
studies for identifying genetic pleiotropy of age-related diseases
and endophenotypes still lag behind. In recent years, a
handful of statistical frameworks based on multivariate or
univariate approaches have been proposed (Solovieff et al.,
2013). Multivariate models are one of the extensively adopted
approaches that have been proposed to deal with multiple
phenotypes in a unified framework (O’Reilly et al., 2012; Shriner,
2012). Multivariate approaches take into account phenotypic
correlation but often have some limitations in the context of
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meta-analysis and drawbacks of being incapable of handling
phenotypes of different types. For example, it may suffer from
reduced statistical power due to removal of subjects with
missing values in any phenotype. When searching for the
pleiotropy between age-related diseases and endophenotypes, we
often face the problem of combining time-to-event outcomes
and quantitative or binary traits. In this situation, univariate
approaches based on p-values (Fisher, 1925; van der Sluis et al.,
2013) or summary statistics (Xu et al., 2003; Zhu et al., 2015)
exhibit unique advantages in terms of both statistical power and
flexibility. In particular, pleiotropic analysis by systematically
combining summary statistics based on existing GWAS results
that also takes into account phenotype correlation can be a fast
and simple solution to this issue (Zhu et al., 2015).
In this study, we aim at identifying SNPs that exhibit effects
on multiple endophenotypes and age-related diseases including
CVDs, cancer, DM and NDs by performing a pleiotropic meta-
analysis based on five National Institutes of Health (NIH)-
funded large-scale longitudinal datasets. We use a slightly
modified strategy based on (Zhu et al., 2015) to combine
summary statistics from univariate association studies that takes
into account the correlation between the statistics for the
endophenotypes and diseases. For each newly identified variant
that passes a pre-specified significance threshold, we explore its
biological implication and regulatory role by performing follow-
up functional annotation and examining Encyclopedia of DNA
Elements (ENCODE) (The ENCODE Project Consortium, 2012)
and Genotype-Tissue Expression project (GTEx) (Lonsdale et al.,
2013) databases. This helps detect spurious pleiotropy that may
result from linkage disequilibrium (LD) with two causal variants
in different genes affecting different endophenotypes or diseases
(Solovieff et al., 2013). We further conduct age-dependent time-
to-event analyses to investigate temporal patterns of the effects.
To distinguish two different types of pleiotropy, we perform a
follow-up mediation analysis using a marginal structural model.
In particular, to provide more insight into the plausible causal
pathways, we focus on studying whether or how much the effect
of an identified SNP on an associated disease is mediated through
a specific endophenotype.
MATERIALS AND METHODS
Study Cohorts
The phenotypic and genotypic data used in this study were
collected from the Atherosclerosis Risk in Communities study
(ARIC) (http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/
study.cgi?study_id=phs000090.v1.p1), the Framingham Heart
Study (FHS) (http://www.ncbi.nlm.nih.gov/projects/gap/cgi-
bin/study.cgi?study_id=phs000007.v28.p10), the Multi-Ethnic
Study of Atherosclerosis (MESA) (http://www.ncbi.nlm.nih.
gov/projects/gap/cgi-bin/study.cgi?study_id=phs000209.v2.p1),
the Cardiovascular Health Study (CHS) (http://www.ncbi.nlm.
nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000287.
v3.p1), and the Health and Retirement Study (HRS) (http://
www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_
id=phs000428.v1.p1; http://hrsonline.isr.umich.edu/). For FHS,
we included the datasets of the FHS Original cohort (FHS
cohort 1) and the FHS Offspring cohort (FHS cohort 2). Details
of the study design, collection of samples, measurement of
phenotypes and genotyping have been described in previous
publications [ARIC: (The ARIC investigators, 1989; Sharrett,
1992), FHS: (Splansky et al., 2007; Govindaraju et al., 2008;
Cupples et al., 2009), MESA: (Bild et al., 2002), CHS: (Gottdiener
et al., 2000), HRS: (Sonnega et al., 2014)]. In each study, we only
included non-Hispanic Caucasian subjects. Table 1 summarizes
the basic characteristics of the samples and provides a list of
the phenotypes we investigated. We included all longitudinal
observations of these phenotypes available throughout the
follow-up in these studies except HRS in which only one
observation was available from the examinations in 2006–2008.
The binary outcomes were adopted for the diseases in HRS of
which the age-at-onset outcomes were not available. Specifically,
we included phenotype measurements from 4 visits in ARIC, 28
visits in the FHS cohort 1, 8 visits in the FHS cohort 2, 5 visits in
MESA, and 22 examinations in CHS. For FHS, we performed the
analyses for the two cohorts separately to account for potential
generation confounders.
Accession Numbers
This manuscript was prepared using a limited access dataset
obtained though dbGaP (accession numbers phs000007.v22.p8,
phs000280.v2.p1, phs000209.v12.p3, phs000287.v3.p1).
Genotyping, Imputation, and Quality
Control
Genotyping of 12,771 ARIC participants (N = 9633 whites, N =
9618 included) and 8224 MESA participants (N = 2686 whites,
N = 2455 included) was conducted using an Affymetrix 6.0
array (1000 K SNPs). Genotyping of 9167 participants (N = 4594
whites included) in FHS was conducted using an Affymetrix 500
K array. Genotyping of 3043 participants in CHS was done using
a HumanOmni1-Quad Illumina array. In HRS,∼2.5M SNPs for
12,507 subjects (N = 9736 whites, N = 9704 included) were
genotyped using an Illumina HumanOmni 2.5 Quad chip. All
genotyped SNPs were further filtered for the analysis according to
the exclusion criteria of the Hardy-Weinberg equilibrium (HWE)
test (p < 1e-05) and missing rate (>5%). For the SNPs that were
selected as candidates from ARIC (described in the following
subsection) and were missing in the other studies, we imputed
the genotypes with IMPUTE2 (Howie et al., 2009) according to
a 1000 Genomes Project Phase I reference panel. Within each
study, those SNPs with an imputation information score < 0.8
were excluded from the analyses.
Selection of Candidate SNPs
To narrow down the candidates and pre-select promising
SNPs, we focused on one of the largest studies ARIC,
which shared the same genotyping platform with MESA, and
reported a wide spectrum of measured relevant phenotypes
and diseases. Accordingly, we expected larger enrichment of
significant SNPs associated with various age-related diseases
and related traits in this study compared to the others. SNPs
pre-selected in ARIC have been considered as a starting
point for the follow-up meta-analyses to replicate their effects
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TABLE 1 | Basic characteristics of the samples, endophenotypes, and diseases in the six cohorts included in the analyses.
Study Total
observations
Sample
sizea
Number of
families
Ageb Female
(%)
Endophenotypec Diseases or deathd
ARIC 38,472 9618 9093e 54.32 52.99 VR, BG, BMI, SBP, DBP, HDLC, TG, TC,
HC
AF, Cancer, CHD, DM, HF,
Stroke, Death
FHS
C1
30,212 1079 675 37.68 61.08 VR, BG, BMI, SBP, DBP, HDLC, TG, TC,
HC
Cancer, CHD, DM, ND, HF, IC,
Stroke, Death
FHS
C2
28,120 3515 1191 35.42 52.83 VR, BG, BMI, SBP, DBP, HDLC, TG, TC Cancer, CHD, DM, ND, HF, IC,
Stroke, Death
MESA 12,275 2455 2421 62.67 52.06 VR, BG, BMI, DBP, HDLC, TG, TC, PP,
HbA1c
CHD, CVD, DM, HF, Death
CHS 66,946 3043 3043 72.39 60.4 VR, BG, BMI, SBP, DBP, HDLC, TG, TC,
HC, Creatinine, CRP, FEV1
AD, Cancer, CHD, CVD, DM, HF,
Death
HRS 9704 9704 9643 58.13 57.95 BG, BMI, HDLC, TC, CRP, Cystatin C Cancer, DM, stroke, HBP, Lung,
Psych, Arthr, CHD, Death
aThe sample size corresponds to the number of subjects after exclusion of those with the missing rate >0.05.
bAverage age of the individuals included at the entry of the follow-up.
cAll endophenotypes included were quantitative traits. SBP was not included in the pleiotropic analysis for MESA as it was highly correlated with PP (r = 0.83) and DBP (r = 0.71)
(Figure S4). FVC was not included in the pleiotropic analysis for CHS as it was highly correlated with FEV1 (Figure S5). PP, pulse pressure, HbA1c, Hemoglobin A1c. CRP, C-reactive
protein. Log-transformation (100*log(.)) was performed for VR, BG, BMI, HDLC, TC, TG, and PP to correct for their distribution skewness.
dCancer, DM, Stroke, Lung (lung diseases), Psych (Psychiatric diseases), Arthr (Arthritis), CHD in HRS were binary traits, and the others were time-to-event traits. HBP, IC, and AD refer
to hypertension, intermittent claudication, and Alzheimer’s diseases, respectively. ND in the FHS cohorts included AD and dementia.
eThe number of families in ARIC was estimated from a kinship matrix based on the genotype data of the ARIC subjects.
in other studies. We first conducted univariate GWAS of
the SNPs with minor allele frequency (MAF)>2% in ARIC
for the endophenotypes [ventricular rate (VR), blood glucose
(BG), BMI, systolic blood pressure (SBP), diastolic blood
pressure (DBP), high-density lipoprotein cholesterol (HDLC),
total cholesterol (TC), triglycerides (TG), hematocrit (HC)], the
diseases [atrial fibrillation (AF), cancer, coronary heart disease
(CHD), DM, heart failure (HF), stroke] and mortality using
PLINK software (Purcell et al., 2007). An additive genetic coding
model was adopted in all the studies performed at the current
and following stages.We computed combined p-values across the
endophenotypes and diseases using Fisher’s method which did
not take into account phenotype correlation and thus at this stage
produced less stringent results in most cases. The SNPs with a
p-value exceeding the genome-wide significance threshold (5e-
08) were chosen as candidates for the downstream pleiotropic
meta-analysis.
Univariate Association Analysis
For the selected SNPs, we conducted univariate association
analyses separately in each study to obtain summary statistics.
The phenotypes and diseases under investigation in each
study are listed in Table 1. We adopted a (generalized) linear
mixed-effects model with both individual- and family-level
random effects to control for family structure and longitudinal
observation correlation in ARIC, FHS, and MESA, and with only
an individual-level random effect in CHS which consisted of only
independent individuals. We adopted a linear regression model
for HRS as we only selected cross-sectional measurements and
more than 99% of the samples were independent. We adopted
marginal Cox proportional hazards (PH) models to analyze the
time-to-event phenotypes with robust estimates of variance (Lin
and Wei, 1989) for correcting for family structure. We included
age and sex as covariates in the analysis of each study. In addition,
we included study center as a covariate in ARIC, MESA and
CHS, cohort in HRS, and genotyping phase in FHS. We utilized
the lmer and lm functions in the lme4 R package (Bates et al.,
2014) for the quantitative analyses, glm for the logistic regression
(only for HRS) and the coxph function in the survival R package
(Therneau and Lumley, 2015) for the time-to-event analyses.
Log-transformation was performed to correct the skewness of the
distribution for certain quantitative phenotypes (Table 1).
Pleiotropic Meta-Analysis
The overall framework of the entire meta-analysis is depicted in
the flowchart (Figure 1). Given that Fisher’s method does not
account for the correlation between the statistics, inflated p-
values were expected in the pre-selection stage as most of our
phenotypes were weakly to modestly correlated (Figures S1–S6).
Therefore, we adopted a two-step strategy to compute more
accurate meta-analysis combined p-values for the selected SNPs.
More specifically, suppose that for a certain SNP we observe
an estimated effect size β̂ij together with its standard error σ̂ij
for the phenotype i (i ∈ {1,. . .,Kj}) in the study j (j ∈
{1, 2, 3, 4, 5, 6}), where Kj is the number of phenotypes in the
study j. In the first step, following the similar spirit of (Xu et al.,
2003; Bolormaa et al., 2014; Zhu et al., 2015), we constructed
a general omnibus test statistic ẑ′j6
−1
j ẑj that took into account
the correlation of effect sizes between the phenotypes, where
ẑj = β̂ j/σ̂ j (β̂ j = (β̂1j, . . . , β̂Kjj)
′ and σ̂ j =
(
σ̂1j, . . . , σ̂Kjj
)′
) and
6j is the correlation matrix to be estimated. Thus, under the null
hypothesis (β j = 0) and the assumption of a large sample size,
the test statistic approximately follows a chi-square distribution
with a degree of freedom (DF) of Kj
ẑ’jΣ j
−1ẑj∼χ
2
K j
,
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FIGURE 1 | A flowchart of the meta-analysis of the pleiotropic studies using the five NIH-funded datasets. As shown in the figure, the meta-analysis
consists of three stages. In the first stage, 343 promising candidate SNPs were selected from ARIC. Next, association tests for each endophenotype and disease
were performed in each of the five cohorts, and the summary statistics were used to construct three phenome-wide meta-analysis p-values (endophenotypes,
diseases and both) using the omnibus test. Finally, the p-values from each cohort were combined using Fisher’s method.
from which we obtained a combined p-value pj in the study
j. As independent SNPs are recommended for estimating Σ j
(Zhu et al., 2015), we simulated 1000 independent SNPs under
HWE based on MAF and estimated the correlation matrix Σj
for each study j based on the summary statistics of the simulated
SNPs. The endophenotypes included in the pleiotropic analysis
are purported to affect the onset of the complex diseases to some
extent. We observed that the majority of the pairwise correlations
of the summary statistics from the univariate analysis were
lower than 0.3. As combining evidence from highly correlated
phenotypes is less informative, within each study, we selected
a group of phenotypes (Table 1) to ensure that the correlation
between any pair of z-scores was less than 0.7 (The correlation
matrices of the statistics in the five datasets are depicted in
Figures S1–S6). A p-value (e.g., pj) that was smaller than a pre-
specified threshold led to the rejection of the null hypothesis,
indicating that the SNP was associated with at least one of the
phenotypes in the study j (i.e., ∃i,β ij 6= 0). Then, we computed a
p-value for the meta-analysis using the Fisher’s method in which
the samples from the six cohorts were treated as independent
(we did not observe evident correlation between the summary
statistics under the null hypothesis from the two generations in
FHS). Thus, under the null hypothesis (i.e., the SNP was not
associated with any phenotype in any study), the test statistic for
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the meta-analysis followed a chi-square distribution with a DF
of 12.
(−2)
∑
j
In(pj)∼χ
2
12,
Fromwhich we obtained ameta-analysis p-value pM . We adopted
the broadly recognized genome-wide significance pM<5e−08 as
a threshold to declare the significant SNPs.
Functional Annotation
We first pruned the identified SNPs from the pleiotropic meta-
analysis to select independent SNPs to represent adjacent loci
in high LD for the follow-up studies. LD information for each
pair of SNPs was acquired using SNAP (Johnson et al., 2008)
and the identified SNPs on each chromosome were aggregated
into groups based on pairwise correlation coefficients of LD
(i.e., r2). More specifically, a SNP was merged into a group
if it was in high LD (r2 > 0.5) with any SNP in the group.
We selected the SNP with the most significant p-value within
each group as the proxy. To highlight novel SNPs for the
downstream analyses, we examined the identified proxy loci
in the Ensembl database and employed GRASP (Leslie et al.,
2014) to search GWAS catalog data for previously reported
associations. Functional consequences of these identified proxy
SNPs were annotated using the Ensembl Variant Effect Predictor
(McLaren et al., 2010). To check whether these SNPs had a
plausible role in gene expression, we examined whether they
were eQTLs or in LD with eQTLs of associated genes. We
retrieved information on eQTLs in the gene which the SNP is
located in or is flanked by from the GTEx database (Lonsdale
et al., 2013) for all available tissues and acquired pairwise LD
information using SNAP (Johnson et al., 2008). We examined
various regulatory features such as DNase clusters, chromatin
interactions, DNA methylation, histone modification from the
ENCODE database (The ENCODE Project Consortium, 2012)
through the UCSC genome browser. We examined variants
in high LD (r2 > 0.8) with the identified SNPs in non-
coding regions for their functional annotation and the presence
of chromatin histone marks, hypersensitive DNase elements
and protein binding sites from the ENCODE and Roadmap
databases by using the HaploReg v3 software (Ward and Kellis,
2012).
Analysis of Age-Dependent Effects
In order to ensure that the SNPs identified from the time-to-event
analysis satisfied the PH assumption and explore their potential
age-dependent effects, we checked the model fitting based on the
correlation coefficient between transformed survival time and the
scaled Schoenfeld residuals (Grambsch and Therneau, 1994). We
declared the violation if the p-value from the cox.zph function
in the survival R package was <0.05. Any violation of the PH
assumption indicated the existence of age-dependent effects, and
for such SNPs we acquired an overall picture of its dynamics of
the age-dependent effect by utilizing the timecox function in the
timereg R package (Martinussen and Scheike, 2007), in which
we assumed that the counting process started at the age of 40
as data is modeled by a counting process representation in this
method. Other covariates such as sex that did not violate the
PH assumption were treated as constants and a cluster-based
resampling method was used to correct for the family structure.
Based on the produced temporal pattern of the dynamic effects,
we further performed stratification analyses to investigate the
specific effects in each age group.
Mediation Analysis
For the SNPs identified to be associated with both the
endophenotypes and complex diseases, we performed mediation
analysis to investigate whether the pleiotropic effect is mediated
by the endophenotypes (natural indirect effect) or through other
unspecified mechanisms (natural direct effect). The rationale
of the mediation analysis is illustrated in the causal graph
(Figure 2). In the longitudinal data, we chose the measurement
at the baseline of an endophenotype as a mediator, which ruled
out the possibility of reverse causality for most diseases (except
cancer) as the measurements occurred well before the onset of
diseases. Due to the Mendelian randomization, in general there
should be no confounder other than population stratification
between the SNPs and the mediators or diseases. We included
age and sex as covariates and further assumed that there were
no other unmeasured confounders between the assignment of
a mediator at the baseline and a disease. We followed a unified
approach proposed by Lange et al. (2012) based on marginal
structural models (MSMs) (Robins et al., 2000) to estimate the
natural direct and indirect effects. We adopted linear regression
for the mediator model, and the Cox PH model for the outcome
model. Robust standard errors were obtained using a cluster-
based non-parametric bootstrapmethod, as suggested by Rochon
et al. (2014), with 500 replicates to control for the family
structure. A detailed description of the method for the mediation
analyses is provided in the supplementary materials Text S1.
RESULTS
Pleiotropic Meta-Analysis Identifies Seven
Novel Loci
The pre-selection GWAS highlighted 343 SNPs from ARIC that
were included in the pleiotropic meta-analysis. If a SNP was not
genotyped in the other studies, the imputed genotypes were used
if passing the quality control (the detailed information on each of
the SNPs is listed in Table S1). The effect sizes and HRs (or ORs)
from the association tests in each study are presented in Table S2.
Based on the summary statistics, we performed three pleiotropic
meta-analyses for: (A) the endophenotypes, (B) the diseases,
(C) both. Consequently, out of the 343 SNPs, 148, 11, and 147
SNPs had a p-value surpassing the genome-wide significance
threshold (5e-08) in each analysis, respectively (Table S1). Four
SNPs (rs4506565, rs7901695, rs4132670, and rs8082812) showed
significant association in all three analyses, in which the first three
are located in TCF7L2. After pruning the SNPs based on LD and
p-values, we ended up with 28, 9, and 28 independent proxy
SNPs. After functional annotation and examining the GWAS
catalog, we identified three novel SNPs from the analysis of (B)
alone: rs7081476 on 10p12.1 located in an intron of ANKRD26
(p = 2.47e-08), rs12420422 on 11q24.1 flanked by BSX (∼20 kb)
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FIGURE 2 | A diagram of the mediation analysis. This diagram illustrates
the assumed causal relationship between the entities involved in the mediation
analysis and their temporal pattern. PH: a quantitative trait treated as a
mediator. In this case, it was an endophenotype of interest. OC: observed
confounders such as sex and age. UC: potential unmeasured confounders. In
the mediation analysis, we assumed that there was no unmeasured
confounder behind the baseline measurement of the mediator and the onset
of the disease under investigation. Vertical dash line: the time point at the
measurement of the mediator.
and HSPA8 (∼40 kb) (p = 5.21e-10) and rs460976 in TMPRSS2
on 21q22.3 (p = 1.37e-08), one novel SNP rs1869717 on 4q31.3
in an intron of MAML3 from the analysis of (C) alone (p =
4.82e-08), two novel SNPs from both analyses of (B) and (C):
rs7632505 on 3q21.1 located in an intron of SEMA5B (p = 8.04e-
22 and 7.26e-19), rs4905014 on 14q32.12 located in an intron of
ITPK1 (p = 4.93e-16 and 8.85e-15), and rs8082812 on 18p11.22
from all three analyses (p = 4.44e-08, 5.71e-64, and 5.01e-
67). No novel SNPs were identified from the analysis of (A)
alone. Five out of the seven highlighted SNPs are low-frequency
variants (1% < MAF < 5%) (The detailed information is given
in Table 2).
Mediated Pleiotropic Effects of rs7081476
on Diseases through Endophenotypes
The univariate association tests show that rs7081476 was at
least nominally (p < 0.05) associated with a variety of
endophenotypes and diseases across multiple studies, including
BMI (p = 2.82e-03 in ARIC), SBP (p = 1.51e-02 in ARIC),
HDLC (p = 6.64e-03 in ARIC), TG (p = 3.24e-02 in ARIC), BG
(p = 1.95e-02 in MESA), hemoglobin A1c (HbA1c) (p = 3.44e-
03 in MESA), AF (p = 2.88e-03 in ARIC), HF (p = 8.32e-03
in ARIC), CHD (p = 5.50e-10 in ARIC), DM (p = 4.89e-02 in
ARIC, p = 4.78e-04 in MESA), ND (p = 9.18e-03 in FHS cohort
2), and stroke (p = 7.62e-03 in ARIC, p = 2.48e-02 in HRS)
(Table 3). The minor allele of this low-frequency variant was
associated with elevated BMI, SBP, TG, BG, HbA1c, and reduced
HDLC levels. It was associated with increased hazards of AF, HF,
CHD, stroke, DM, and reduced hazard of ND consistently across
the studies. Based on the GTEx database, rs7081476 is an eQTL
of the gene MASTL (p = 9.2e-06). Furthermore, rs7081476 is in
modest LD (the LD structure of CEU estimated from the 1000
Genomes pilot 1) with rs12573313 (r2 = 0.248) and rs7069690 (r2
= 0.263), which are eQTLs affecting the expression of multiple
genes including MASTL, LINC00202-1, etc, in numerous tissues
(Table S4). Rs7081476 and multiple variants in high LD (r2 >
0.8) located in ANKRD26 were found in strong enhancers in
the B-lymphoblastoid cell lines (Table S5). We observed indirect
effects, albeit small (<10% of the total effects), of rs7081476 on
stroke, HF and CHD that were partly mediated through BMI,
SBP, TG, andHDLC. Themediation analyses also suggest that the
effect of rs7081476 on DMwas partly mediated through BMI and
HDLC in ARIC and predominantly through HbA1c in MESA
(Table S3).
Rs12420422 and rs460976 Are Associated
with Heart Related Diseases
Rs12420422 was nominally associated with the hazards of AF
(p = 1.96e-02), HF (p = 3.18e-03), CHD (p = 5.20e-
17), and death (p = 1.65e-02) in ARIC. A missense variant
rs2276348 located in CLMP was found to be in high LD
(r2 = 0.91) with rs12420422 (Table S5). Multiple variants in
high LD (r2 > 0.8) with rs12420422 were found within strong
enhancers in multiple cell lines (Table S5). The minor allele of
rs12420422 increased the hazards of AF, HF, CHD, and death.
Rs460976, a downstream gene variant of TMPRSS2 located in
a copy number variation (CNV) (esv3647063), was associated
with HF (p = 2.99e-04) and CHD (p = 1.13e-16) in ARIC
(Table 3). Rs460976 is in modest LD with rs7280422 (r2 =
0.124), which is an eQTL associated with the expression of
MX1 in transformed fibroblasts, testis and tibial artery tissues,
and rs11910387 (r2 = 0.141), which is an eQTL associated
with the expression of MX2 in adipose-subcutaneous and skin
(Table S4).
Rs7632505 Is Associated with BG and TG,
and Has an Age-Dependent Effect on CHD
The univariate association tests indicate that rs7632505, a non-
sense-mediated mRNA decay transcript variant, was nominally
associated with BG (p = 4.83e-03), TG (p = 2.61e-02),
HF (p = 7.30e-08), and stroke (p = 2.14e-02) in ARIC,
BMI (p = 2.17e-02), TC (p = 4.00e-02), and VR (p =
2.78e-02) in FHS, CHD in ARIC and MESA (p = 2.75e-
28 and 2.87e-02) and DM in HRS (p = 1.27e-02) (Table 2).
Rs7632505 is in modest LD with rs72974405 (r2 = 0.342) and
rs9829771 (r2 = 0.283), which are eQTLs associated with the
expression of PDIA5 in tibial artery tissues (Table S4). The
test of the PH assumption suggests that the effect on the
hazard of CHD was far from proportional (p = 1.5e-05 from
cox.zph) (Table 3). The age-dependent analysis using the timecox
function shows that the effect on the hazard of CHD dropped
dramatically after the age of ∼70 (Figure 3A). The survival
curves from the Kaplan–Meier (K-M) estimator were consistent
(Figure S7). The stratified analysis suggests that the minor allele
increased the hazard of CHD before the age of ∼74 (Age 45–
74: HR = 1.498, p = 2.92e-27) while decreases it after that
(Age 75–85: HR = 0.769, p = 0.101). No mediation effects
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TABLE 2 | Basic information of the seven identified SNPs with the p-values from the pleiotropic meta-analysis and MAFs acorss the five cohorts.
SNP ID Chr Positiona A1 A2 Associated or
flanking gene
Pb Pc Pd MAFe
rs7632505 3 123019460 A G SEMA5B (intron) 1.11e-01 8.04e-22 7.26e-19 ARIC: 34.23%, MESA: 37.63%, FHS1: 16.07
(imp), FHS2: 14.79% (imp), CHS: 23.8% (imp),
HRS: 23.5% (imp)
rs1869717 4 139829967 G C MAML3 (intron) 6.91e-04 1.68e-05 4.82e-08 ARIC: 3.19%, FHS1: 3.05%, FHS2: 3.70%,
CHS: 8.80% (imp), MESA: NA, HRS: 7.90% (imp)
rs7081476 10 26969741 G C ANKRD26 (intron) 1.76e-01 2.47e-08 4.75e-06 ARIC: 2.12%, MESA: 1.87%, FHS1: 1.81%,
FHS2: 2.56%, CHS: 3.1% (imp), HRS: 4.1% (imp)
rs12420422 11 123009573 G A BSX (∼20 kb), HSPA8
(∼40 kb)
8.72e-01 5.21e-10 1.63e-07 ARIC: 2.23%, FHS1: 2.42%, FHS2: 1.67%,
MESA: 1.77%, CHS: NA, HRS: 1.74%
rs4905014 14 92945686 G C ITPK1 (intron) 2.96e-02 4.93e-16 8.85e-15 ARIC: 2.85%, MESA: 1.70%, FHS: NA, CHS:
NA, HRS: NA
rs8082812 18 8522684 C A intergenic 4.44e-08 5.71e-64 5.01e-67 ARIC: 2.41%, MESA: 0.37%, HRS: 2.1% (imp),
FHS: NA, CHS: NA
rs460976 21 41463567 G A TMPRSS2 (∼1 kb) 9.24e-01 1.37e-08 4.32e-06 ARIC: 2.33%, MESA: 2.16%, FHS1: 0.81%,
FHS2: 1.30%, CHS: 2% (imp), HRS: 2.26%
aThe position information is based on the genome assembly version: GRCh38.p5.
bThe p-values from the pleiotropic meta-analysis of quantitative endophenotypes.
cThe p-values from the pleiotropic meta-analysis of combined complex diseases.
dThe p-values from the pleiotropic meta-analysis of both.
eThe MAFs (A2 is the coding allele) were estimated from the subjects included in the pleiotropic analysis. The expected MAF from IMPUTE2 is reported, denoted by (imp), when a SNP
was imputed in that study. NAs imply that the SNP was excluded from that study.
through BG or TG were observed on CHD, HF, or stroke
(Table S3).
Rs4905014 Has an Age-Dependent Effect
on Stroke
Nominally significant association of rs4905014 was observed
with HC (p = 9.78e-04) and stroke (p = 3.75e-21)
in ARIC, and with DBP (p = 2.55e-02), HbA1c (p =
1.44e-02), and HF (p = 2.58e-02) in MESA (Table 3). The
minor allele of this low-frequency variant was associated with
elevated HC, HbA1c levels, increased hazards of stroke and
HF, and decreased DBP levels. The PH test suggests that
the hazards of CHD were not proportional with respect to
the SNP (p = 6.8e-03 from cox.zph). The time-dependent
analysis using the timecox function shows that the effect on
stroke was age-dependent (Figure 3B), and the detrimental
effect on the hazard of stroke remained almost imperceptible
until age 62 but accelerated substantially after the age of ∼70.
The survival curves from the K-M estimator were consistent
(Figure S7). The stratified analysis shows that the HRs before
and after age 62 were 1.8408 (p = 0.077) and 3.748 (p =
2.38e-25), respectively. The annotation using the Ensembl
Variant Effect Predictor shows that rs4905014 is located in a
promoter flanking region of a transcript of ITPK1 in multiple
cell types (ENSR00001854796). Rs4905014 is within a DNase
hypersensitive site in the neuroblastoma cell line (SK-N-SH_RA)
and multiple variants in high LD (r2 > 0.8) were found in
strong enhancers in multiple cell lines from the ENCODE
database (Table S5). The mediation analysis suggests that no
mediation effect through HC was observed on the hazard of
stroke (Table S3).
Rs8082812 and rs1869717 Are Associated
with Both Endophenotypes and Diseases
Rs8082812 was found to be at least nominally associated with
BG (p = 2.63e-07), DBP (1.07e-02), HDLC (p = 8.12e-03), TC
(4.64e-05), the hazards of death (p = 1.46e-03), AF (p = 5.99e-
03), HF (p = 1.66e-07), CHD (p = 3.37e-37), and stroke (p =
3.40e-41) in ARIC and BMI (p = 3.83e-02) in MESA (Table 2).
The minor allele of this SNP was associated with elevated BG
and TC levels, increased hazards of AF, CHD, stroke, HF and
death, and decreased DBP and HDLC levels. The test of the PH
assumption suggests that the effect of the SNP on the hazard
of stroke was not proportional (p = 2.91e-03 from cox.zph)
and the time-dependent analysis shows that the effects on the
hazards of CHD and stroke were age-dependent and exhibited
different temporal patterns (Figures 3C,D). The survival curves
from the K-M estimator were consistent (Figure S7). The effect
on CHD remained modest before age 60, increased dramatically
between ages 60–70 and leveled off subsequently. The stratified
analysis shows that the effect on stroke wasmuch larger andmore
significant before age 73 than after that (HR = 8.23, p = 3.47e-
54 vs. HR = 1.78, p = 0.229). We further noticed that one
copy of minor allele had an HR of 7.27 (p = 1.01e-51) while
two copies had no significant effect (HR = 2.39, p = 5.82e-
02) on stroke. Functional annotation suggests that rs8082812
is located in a DNase hypersensitive site in the fibroblasts and
urothelial cell lines (Table S5) and close to a copy number
variation (∼1.4 kb) (Ensembl ID: esv3641717). The mediation
analysis suggests that the effect of rs8082812 on the hazard of
HF was partly mediated through HDLC, while the effect on CHD
was partly mediated through BG and TC (Table S3). Rs1869717,
located inMAML3 and an enhancer region (ENSR00002016330),
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TABLE 3 | Nomially significant associations of the seven novel SNPs
identified from the univariate analyses in each cohort.
SNP ID Study Trait Effect sizea Pb (< 0.05) Pc
rs7632505 ARIC BG 0.792 4.83e-03 NA
TG 1.51 2.61e-02 NA
HF 0.269 7.30e-08 5.67e-01
CHD 0.402 2.75e-28 1.5e-05
Stroke −0.176 2.14e-02 5.75e-01
FHS C1 BMI −1.792 2.17e-02 NA
TC −1.695 4.00e-02 NA
FHS C2 VR 0.929 2.78e-02 NA
CHS CHD 0.139 2.87e-02 2.92e-01
HRS DM 0.11d 1.27e-02 NA
rs1869717 ARIC DBP −0.745 1.83e-02 NA
TC 1.828 6.01e-03 NA
HF 0.287 1.74e-02 1.75e-01
CHD 0.516 7.20e-10 5.64e-01
Stroke 0.412 1.19e-02 3.21e-01
FHS C1 TG −12.355 2.05e-02 NA
Stroke 0.589 1.01e-02 5.69e-01
Death 0.470 2.59e-04 5.53e-01
CHS BMI −2.451 3.42e-02 NA
SBP −4.484 7.35e-04 NA
HDLC 4.837 4.70e-03 NA
TG −7.805 9.66e-03 NA
FEV1 −0.095 9.45e-03 NA
HRS BG 1.727 2.39e-03 NA
DM 0.19d 4.33e-02 NA
rs7081476 ARIC BMI 2.51 2.82e-03 NA
SBP 1.626 1.51e-02 NA
HDLC −3.54 6.64e-03 NA
TG 4.68 3.24e-02 NA
DM 0.0489 4.89e-02 4.95e-01
AF 0.412 2.88e-03 8.36e-02
HF 0.363 8.32e-03 6.16e-01
CHD 0.582 5.50e-10 7.32e-01
Stroke 0.492 7.62e-03 5.76e-01
FHS C2 ND −1.884 9.18e-03 8.01e-01
MESA BG 3.42 1.95e-02 NA
HbA1c 0.18 3.44e-03 NA
DM 0.626 4.78e-04 4.95e-01
CHS HF 0.437 5.07e-03 1.41e-01
HRS Stroke 0.286d 2.48e-02 NA
Death 0.26 1.88e-02 2.53e-01
rs12420422 ARIC Death 0.266 1.65e-02 1.75e-01
AF 0.331 1.96e-02 7.60e-01
HF 0.425 3.18e-03 5.96e-01
CHD 0.775 5.20e-17 8.41e-01
FHS C1 DBP 2.384 1.62e-02 NA
rs4905014 ARIC HC 0.376 9.78e-04 NA
(Continued)
TABLE 3 | Continued
SNP ID Study Trait Effect sizea Pb (< 0.05) Pc
Stroke 1.166 3.75e-21 6.8e-03
MESA DBP −1.925 2.55e-02 NA
HbA1c 0.17 1.44e-02 NA
HF 1.029 2.58e-02 5.65e-01
rs8082812 ARIC BG 4.042 2.63e-07 NA
DBP −0.827 1.07e-02 NA
HDLC −2.993 8.12e-03 NA
TC 2.778 4.64e-05 NA
Death 0.279 1.46e-03 4.49e-01
AF 0.305 5.99e-03 2.21e-01
HF 0.538 1.66e-07 4.86e-01
CHD 0.848 3.37e-37 1.43e-02
Stroke 1.226 3.40e-41 2.91e-03
MESA BMI 8.018 3.83e-02 NA
rs460976 ARIC HF 0.468 2.99e-04 1.39e-01
CHD 0.714 1.13e-16 2.92e-01
FHS C2 TG −9.927 3.08e-02 NA
HRS DM 0.22 4.14e-02 NA
aLog-transformation (100*log(.)) was performed on the original measurements for some of
the endophenotypes (Please refer to Table 1 for the details). For the time-to-event traits,
this is log(HR).
bThe p-value of the association with an endophenotype or a disease from that cohort.
cThe p-value from the cox.zph function for checking the PH assumption. A p-value< 0.05
leads to rejection of the assumption. It is not available for quantitative traits.
dThis is an OR as prevalence was used instead of time-to-event traits in HRS.
was at least nominally associated with DBP (p = 1.83e-02), TC
(p = 6.01e-03), HF (p = 1.74e-02), CHD (p = 7.20e-10) and
stroke (1.19e-02) in ARIC, stroke (p = 1.01e-02) and death
(p = 2.59e-04) in FHS cohort 1, BMI (p = 3.42e-02), SBP
(p = 7.35e-04), HDLC (p = 4.70e-03), and FEV1 (p = 9.45e-
03) in CHS, BG (p = 2.39e-03) and DM (4.33e-02) in HRS, and
TG in FHS cohort 1 and CHS (p = 2.05e-02 and p = 9.66e-
03) (Table 3). The minor allele of this SNP increased the hazards
of HF, CHD, stroke, DM and death, but exhibited heterogeneous
effects on the endophenotypes. No indirect effects were observed
on any of the diseases in ARIC (Table S3).
DISCUSSION
With the recent discovery of a large number of genes and variants
influencing endophenotypes and diseases simultaneously
(Sivakumaran et al., 2011), pleiotropy has been attracting a
lot of interest. A fundamental hypothesis in gerontology is
that delaying biological aging process, which is assumed to
lead to physical dysfunction and to be implicated in multiple
age-related diseases through common underlying mechanisms
(i.e., pleiotropic effects), would simultaneously delay the onset
and progression of these diseases (Kaeberlein et al., 2015). For
example, chronic diseases of aging including CVDs, cancer and
ND share pathological links through infection and inflammation
(Franceschi, 2007; Larbi et al., 2008; Finch, 2010, 2012).
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FIGURE 3 | Cumulative age-dependent effects of the minor allele on the onset of diseases estimated using the timecox function that fits a
proportional hazards model allowing time-varying effects of the SNPs. The solid lines are cumulative time-varying regression coefficient estimates with respect
to age. The dash lines are 95% pointwise confidence bands. (A) effect of rs7632505 on CHD, (B) effect of rs4905014 on stroke, (C) effect of rs8082812 on CHD, (D)
effect of rs8082812 on stroke.
Searching for pleiotropic genetic variants helps validate these
substantive hypotheses and pinpoints mechanisms that could be
biologically plausible for the most basic processes associated with
aging in human. By performing phenome-wide (more than 20
phenotypes or age-related diseases) association analyses followed
by pleiotropic meta-analyses with five large-scale longitudinal
cohorts, we identified seven novel SNPs that affect multiple
endophenotypes and age-related diseases simultaneously. Five
out of the seven SNPs are low-frequency variants which might be
the reason why they were overlooked in the previous GWAS. It is
worth pointing out that almost all these low-frequency variants
show detrimental effects, the excess of which may suggest the
polygenic inheritance in these diseases (Chan et al., 2014).
Our results suggest that the genome-wide significance of
rs7081476 is achieved by aggregating its association with a
wide spectrum of diseases across different cohorts. Rs7081476
is located in an intron of ANKRD26, which is involved in
hematopoiesis, glucose homeostasis, fat cell differentiation, fatty
acid and lipid metabolism, among the other processes (Fei
et al., 2011; Raciti et al., 2011; Cesar et al., 2015). Mutations
in ANKRD26 or the promoter region have been reported to
cause autosomal dominant non-syndromic thrombocytopenia-
2 (THC2) (low platelet count) (Noris et al., 2011; Pippucci
et al., 2011; Al Daama et al., 2013). Platelets represent an
important connection between inflammation and development
of CVDs (Willoughby et al., 2002; Wagner and Burger, 2003),
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which may justify the association with a variety of CVDs
in our findings. A mouse model also confirmed that partial
inactivation of the ANKRD26 gene caused the development of
extreme obesity, insulin resistance and gigantism (Bera et al.,
2008), which is in line with our findings of DM and BMI.
We further show that the effects of rs7081476 on stroke, HF,
CHD, and DM were mediated through several endophenotypes
among which BMI had the most significant indirect effect. It has
been pointed out that controlling the expression of ANKRD26
would affect megakaryopoiesis and platelet production, perhaps
by inducing apoptosis (Pippucci et al., 2011) or MAPK pathway
hyperactivation (Bluteau et al., 2014). Interestingly, elevated
platelet count may correlate with obesity (Samocha-Bonet et al.,
2008). On the other hand, the neighboring MASTL kinase, of
which rs7081476 is a direct eQTL, is important for cell cycle
regulation and is implicated in normal thrombopoiesis and
association with THC2 (Di Paola and Johnson, 2011). This
evidence indicates that rs7081476 may be involved in regulatory
activity of the genes in THC2 locus functionally related to the
hematopoiesis.
Rs12420422 is an intergenic variant flanked by the genes
BSX (∼28 kb) (encoding a brain-specific homeobox protein)
and HSPA8 (∼48 kb) (encoding a heat shock protein) with
an average MAF of ∼2% estimated from the five cohorts.
While associated with the CVDs (most significantly with CHD)
and mortality, no association was detected with any of the
endophenotypes, which may suggest that the effects on the CVDs
are irrelevant of the pathway related to the endophenotypes
under investigation. Members of the stress-inducible heat-
shock protein family, including HSPA8, are associated with the
development of atherosclerosis and CHD/coronary artery disease
(CAD) (Latchman, 2001; Mehta et al., 2005; He et al., 2010;
Zhang et al., 2014). HSPA8 is also involved in immune response,
the regulation of hematopoiesis and autophagy among the other
processes (Zou et al., 2011; Stricher et al., 2013).
Rs460976 associated with HF and CHD is a low-frequency
downstream gene variant located in an intergenic region flanked
by TMPRSS2 andMX1. Similar to rs12420422, no association was
detected with the selected endophenotypes, suggesting that the
effects on HF and CHD are probably through other mechanisms.
One potential mechanism is through immunological effects.
Indeed, TMPRSS2 has an important role in influenza virus and
other viral respiratory infections whereas MX1 participates in
the cellular antiviral response. CVDs can be associated with
influenza-like illness (Kwok et al., 2015) probably through
immune mechanisms of atherosclerosis (Frostegård, 2013).
Rs7632505 has recently been reported to be associated with
thromboangiitis obliterans (OR = 29.47, p < 1e-04), a chronic
peripheral vascular occlusive disease in a Xinjiang Uyghur
Population (Shi et al., 2016). The dynamic effect of rs7632505
on CHD may be explained by the inhibitory effect of SEMA5B
on angiogenesis which is related to aging process (Lähteenvuo
and Rosenzweig, 2012) and is purported to be involved in
atherosclerosis and other CVDs (Khurana et al., 2005; Deveza
et al., 2012). SEMA5B is a member of the phylogenetically
conserved class 5 semaphorins that all contain a characteristic
Sema domain along with thrombospondin repeats (Adams et al.,
1996) and is functionally important for angiogenesis (Iruela-
Arispe et al., 1999; Chen et al., 2000; Grundmann et al., 2013).
The moderate expression of SEMA5B is detected in multiple
tissues including heart and brain (Nagase et al., 2000). Besides,
SEMA5B functions as a guidance cue and is implicated in
Ca2+-mediated growth cone collapse (To et al., 2007). On the
other hand, rs7632505 may associate with the expression of the
neighboring PDIA5 gene through LD with the eQTLs and PDIA5
is involved in the endoplasmic reticulum (ER) redox homeostasis.
In addition, regulatory activity of the PDIA5 gene is required for
normal hematopoiesis (Gieger et al., 2011; Bielczyk-Maczyn´ska
et al., 2014).
We observed that the effect of rs4905014 on the onset of
stroke grew rapidly after age ∼65, suggesting that it may have an
increasing etiologic effect on stroke for the elderly. Its effects on
stroke and HF were not mediated through HC, DBP, or HbA1c.
The related gene ITPK1 is involved in inositol signaling pathways
which regulate the conductance of calcium-activated chloride
channels (Chamberlain et al., 2007; Saiardi and Cockcroft, 2008).
The enzyme is associated with neural tube defects (Majerus et al.,
2010; Guan et al., 2014). A study using an expression probe array
and rt-PCR has found that ITPK1 expression in peripheral blood
shows a significant correlation with a CAD index (Sinnaeve et al.,
2009).
Rs8082812, located in a DNase hypersensitive site and
surrounded by regulatory regions, is adjacent to (∼300 b)
an enhancer (ENSR00001899253) active in multiple cell lines,
∼1.4 kb from a CNV (esv3641717) and ∼2.4 kb from a CTCF
binding site (ENSR00000667587). RAB12 (∼87 kb) and PTPRM
(∼116 kb) are the closest protein coding genes. RAB12 is
involved in protein transport, degradation of transferrin receptor
and autophagy (Matsui and Fukuda, 2013). Maintenance of
cellular iron homeostasis is indispensable in the management
of diseases and aging, and thus relates to mortality (Altamura
and Muckenthaler, 2009; Weinberg, 2010). Inhibition or over-
activation of autophagy might be associated with various CVDs
(Salabei and Conklin, 2013). PTPRM is required for neurite
outgrowth and axonal migration by regulating adhesion through
the classical cadherins (Oblander and Brady-Kalnay, 2010).
This gene contributes to potassium channels gene regulation
in adult cardiac myocytes by cell-cell contact (Hershman and
Levitan, 2000). Also, PTPRM may play a role in angiogenesis
(Sommer et al., 1997). Its heterogeneous dynamic patterns of
age-dependent effects on the hazards of stroke and CHD may
be partly explained by its effects on a broad spectrum of
endophenotypes.
Rs1869717 is located in MAML3 (Mastermind Like
Transcriptional Coactivator 3), which is a transcriptional
coactivator for NOTCH proteins (Wu et al., 2002). A previous
GWAS finds that another SNP (rs1531070) in MAML3 is
significantly (p = 4.99e-12) associated with congenital heart
malformation in Han Chinese (Hu et al., 2013). Another
genome-wide meta-analysis identifies a locus near this gene that
is associated with protein intake (Tanaka et al., 2013).
To sum up, all of the identified pleiotropic SNPs are either
within a gene or next to regulatory regions, highlighting the
probability of their involvement in gene expression or various
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regulatory activities. A previous report discovers that disease-
associated variants are frequently located in strong enhancer
elements and patterns of enhancer activity are strongly correlated
with patterns of nearest-gene expression (Ernst et al., 2011).
Our results showing that most of the identified variants are
associated with tissue-specific strong enhancers, DNase clusters
or missense variants are consistent with the previous finding. On
the other hand, we further discovered the age-dependent effects
of some SNPs on CHD and stroke, confirming the previous
findings that the effects of variants on the complex diseases in
post-reproductive period could be age-dependent (Kulminski,
2013; Kulminski et al., 2015b; Yashin et al., 2015). It seems that
their pleiotropic effects result from their diverse involvement in
different underlying mechanisms potentially related to nervous,
cardiovascular and immune system functions including axon
guidance and angiogenesis (SEMA5B, PTPRM), ion channels
(SEMA5B, PTPRM, ITPK1), stress resistance, inflammation
and immunity (HSPA8, TMPRSS2/MX1), and hematopoiesis
(ANKRD26, HSPA8). On the other hand, some of the SNPs
such as rs7081476 and rs8082812 are related to lipids or
blood related metabolites. As these metabolites have critical
influence on CVDs, DM and thus eventually mortality, the strong
association of these SNPs with age-related diseases is mediated,
at least in part, through their effects on the metabolites, which
can be classified as mediated pleiotropic effects. Interestingly,
rs7632505 and rs8082812 with age-dependent effects of minor
alleles are linked to genes (SEMA5B, PTPRM) involved in
axonal migration and angiogenesis which are age-dependent
processes.
The power advantage of the pleiotropic analysis can be
demonstrated by rs8082812 for which the p-value from the
pleiotropic meta-analysis was more significant than any from
the univariate analysis. It can be seen from the results of the
pleiotropic analysis for the 343 SNPs that the omnibus test based
on the O’Brien’s test (O’Brien, 1984) increases the statistical
power when the pleiotropic effect of a SNP is heterogeneous
and opposite to the correlation between the statistics from the
univariate analysis. Nevertheless, it may not be the optimal
solution to detecting a SNP that affects two correlated phenotypes
in the same direction through independent paths. Many
extensions to the general omnibus tests have been proposed
by assigning different weights for phenotypes (Xu et al., 2003;
Zhu et al., 2015). In general, no methods are optimal in all
situations, and the choice of these methods depends on the
assumptions we make and the sort of pleiotropic effect we aim
to detect.
Although the large-scale data sets under investigation are
widely recognized and documented, there still exist some
limitations. The definitions and criteria of measurements of
the complex diseases and the targeted populations vary in the
five cohorts. Moreover, some SNPs are not available in other
cohorts as different genotyping chips are adopted in these studies.
Imputation did not come to a rescue for harmonizing missing
data of low-frequency variants as the imputation quality is low.
Because of these, the replication of a significant association
in other cohorts is not straightforward. The lack of some
replications may also suggest that the effects of age-related loci
are more sensitive to environment such as age as many of the
identified SNPs have age-dependent effects. In addition, in terms
of the statistical power of the omnibus test, the inclusion of many
endophenotypes reduces the chance to detect the SNPs that are
only associated with a small proportion of phenotypes. Methods
with adaptive weights on different phenotypes might identify
more signals in this case. Another problem is that although
we assumed that there were no other unmeasured confounders
than the included covariates underlying the endophenotypes
at the baseline and the onset of the complex diseases, it is
still possible that these confounders exist, and in this case,
the estimated mediation effect would be biased (Pearl, 2000).
For example, we observed an indirect effect but no direct
effect of rs7081476 on DM that was mediated through HbA1c.
However, the no-confounder assumption was probably violated
for HbA1c and DM as it has been shown that the association
of HbA1c with DM may be explained by its biomarker for
the presence and severity of hyperglycemia (Lyons and Basu,
2012).
In conclusion, we identified seven novel loci that exhibit
pleiotropic effects on a variety of endophenotypes and age-
related diseases using five large-scale longitudinal cohorts.
The enrichment of identified pleiotropic variants involved in
immune system and inflammation supports the hypothesis
of shared pathological role of infection and inflammation
in chronic age-related diseases. The findings indicating the
potential regulatory involvement of these genetic variants
in a diversity of functions contribute to the understanding
of the shared mechanisms underlying comorbidity and the
relationship between anthropometry, lipid- and blood-related
traits, CVDs, DM, and NDs. Our results suggest that the
effects on the risk of CVDs often follow different age-dependent
patterns and are probably through angiogenesis. These findings
are valuable for guiding follow-up analyses and provide
evidence for further scrutinizing the molecular mechanisms
and implication of the relevant genes in the age-related
diseases.
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estimated from the univariate association analysis in CHS. FVC was
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FEV1 (r > 0.7) (brightly yellow in the figure).
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